Fennec Pharmaceuticals (FENC) intends to engage in a non-brokered offering of its common shares in Canada, at a price of $7.50 per share, with certain of its existing institutional shareholders, for ...
In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, will commercialize PEDMARQSI ® in ...
We are so excited to share that our fennec fox pair, Lidi and George, had a litter of three kits on September 26: two girls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback